0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Point of Care Infectious Disease Testing Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-24X4754
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Point of Care Infectious Disease Testing Market Insights Forecast to 2028
BUY CHAPTERS

Global Point of Care Infectious Disease Testing Market Research Report 2025

Code: QYRE-Auto-24X4754
Report
July 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Point of Care Infectious Disease Testing Market Size

The global market for Point of Care Infectious Disease Testing was valued at US$ 3023 million in the year 2024 and is projected to reach a revised size of US$ 5045 million by 2031, growing at a CAGR of 7.7% during the forecast period.

Point of Care Infectious Disease Testing Market

Point of Care Infectious Disease Testing Market

Infectious disease doctors test your blood or other body fluids to look for specific antibodies — cells produced by our immune system to fight harmful foreign substances. These tests can indicate what kind of infection is present. For bacterial infections, treatment usually involves antibiotics. Launch of mobile & self-testing devices has increased access to testing and monitoring systems to the remote places where the provision of timely medical care is a challenge.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Point of Care Infectious Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care Infectious Disease Testing.
The Point of Care Infectious Disease Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Point of Care Infectious Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point of Care Infectious Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Point of Care Infectious Disease Testing Market Report

Report Metric Details
Report Name Point of Care Infectious Disease Testing Market
Accounted market size in year US$ 3023 million
Forecasted market size in 2031 US$ 5045 million
CAGR 7.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Home
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alere, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers, BD, Chembio Diagnostics, Trinity Biotech, Cardinal Health, Quest Diagnostics, Bio-Rad Labs, bioMérieux, Sight Diagnostics, Gene POC, Trivitron Healthcare, OJ-Bio, Ortho-Clinical Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Point of Care Infectious Disease Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Point of Care Infectious Disease Testing Market growing?

Ans: The Point of Care Infectious Disease Testing Market witnessing a CAGR of 7.7% during the forecast period 2025-2031.

What is the Point of Care Infectious Disease Testing Market size in 2031?

Ans: The Point of Care Infectious Disease Testing Market size in 2031 will be US$ 5045 million.

Who are the main players in the Point of Care Infectious Disease Testing Market report?

Ans: The main players in the Point of Care Infectious Disease Testing Market are Alere, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers, BD, Chembio Diagnostics, Trinity Biotech, Cardinal Health, Quest Diagnostics, Bio-Rad Labs, bioMérieux, Sight Diagnostics, Gene POC, Trivitron Healthcare, OJ-Bio, Ortho-Clinical Diagnostics

What are the Application segmentation covered in the Point of Care Infectious Disease Testing Market report?

Ans: The Applications covered in the Point of Care Infectious Disease Testing Market report are Hospitals, Clinics, Home, Others

What are the Type segmentation covered in the Point of Care Infectious Disease Testing Market report?

Ans: The Types covered in the Point of Care Infectious Disease Testing Market report are HIV POC, HBV POC, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza POC, Others

Recommended Reports

POC Infectious Testing

POC Device & Kits

Diagnostics & Microbiology

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Infectious Disease Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 HIV POC
1.2.3 HBV POC
1.2.4 Pneumonia or Streptococcus Associated Infections
1.2.5 Respiratory Syncytial Virus (RSV) POC
1.2.6 HPV POC
1.2.7 Influenza POC
1.2.8 Others
1.3 Market by Application
1.3.1 Global Point of Care Infectious Disease Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Infectious Disease Testing Market Perspective (2020-2031)
2.2 Global Point of Care Infectious Disease Testing Growth Trends by Region
2.2.1 Global Point of Care Infectious Disease Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Point of Care Infectious Disease Testing Historic Market Size by Region (2020-2025)
2.2.3 Point of Care Infectious Disease Testing Forecasted Market Size by Region (2026-2031)
2.3 Point of Care Infectious Disease Testing Market Dynamics
2.3.1 Point of Care Infectious Disease Testing Industry Trends
2.3.2 Point of Care Infectious Disease Testing Market Drivers
2.3.3 Point of Care Infectious Disease Testing Market Challenges
2.3.4 Point of Care Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Infectious Disease Testing Players by Revenue
3.1.1 Global Top Point of Care Infectious Disease Testing Players by Revenue (2020-2025)
3.1.2 Global Point of Care Infectious Disease Testing Revenue Market Share by Players (2020-2025)
3.2 Global Point of Care Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Point of Care Infectious Disease Testing Revenue
3.4 Global Point of Care Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Point of Care Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Infectious Disease Testing Revenue in 2024
3.5 Global Key Players of Point of Care Infectious Disease Testing Head office and Area Served
3.6 Global Key Players of Point of Care Infectious Disease Testing, Product and Application
3.7 Global Key Players of Point of Care Infectious Disease Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Infectious Disease Testing Breakdown Data by Type
4.1 Global Point of Care Infectious Disease Testing Historic Market Size by Type (2020-2025)
4.2 Global Point of Care Infectious Disease Testing Forecasted Market Size by Type (2026-2031)
5 Point of Care Infectious Disease Testing Breakdown Data by Application
5.1 Global Point of Care Infectious Disease Testing Historic Market Size by Application (2020-2025)
5.2 Global Point of Care Infectious Disease Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Point of Care Infectious Disease Testing Market Size (2020-2031)
6.2 North America Point of Care Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Point of Care Infectious Disease Testing Market Size by Country (2020-2025)
6.4 North America Point of Care Infectious Disease Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care Infectious Disease Testing Market Size (2020-2031)
7.2 Europe Point of Care Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Point of Care Infectious Disease Testing Market Size by Country (2020-2025)
7.4 Europe Point of Care Infectious Disease Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Infectious Disease Testing Market Size (2020-2031)
8.2 Asia-Pacific Point of Care Infectious Disease Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Point of Care Infectious Disease Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Point of Care Infectious Disease Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care Infectious Disease Testing Market Size (2020-2031)
9.2 Latin America Point of Care Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Point of Care Infectious Disease Testing Market Size by Country (2020-2025)
9.4 Latin America Point of Care Infectious Disease Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Infectious Disease Testing Market Size (2020-2031)
10.2 Middle East & Africa Point of Care Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Point of Care Infectious Disease Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Point of Care Infectious Disease Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alere
11.1.1 Alere Company Details
11.1.2 Alere Business Overview
11.1.3 Alere Point of Care Infectious Disease Testing Introduction
11.1.4 Alere Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.1.5 Alere Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Point of Care Infectious Disease Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Point of Care Infectious Disease Testing Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Point of Care Infectious Disease Testing Introduction
11.4.4 Siemens Healthineers Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.4.5 Siemens Healthineers Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD Point of Care Infectious Disease Testing Introduction
11.5.4 BD Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.5.5 BD Recent Development
11.6 Chembio Diagnostics
11.6.1 Chembio Diagnostics Company Details
11.6.2 Chembio Diagnostics Business Overview
11.6.3 Chembio Diagnostics Point of Care Infectious Disease Testing Introduction
11.6.4 Chembio Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.6.5 Chembio Diagnostics Recent Development
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Details
11.7.2 Trinity Biotech Business Overview
11.7.3 Trinity Biotech Point of Care Infectious Disease Testing Introduction
11.7.4 Trinity Biotech Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.7.5 Trinity Biotech Recent Development
11.8 Cardinal Health
11.8.1 Cardinal Health Company Details
11.8.2 Cardinal Health Business Overview
11.8.3 Cardinal Health Point of Care Infectious Disease Testing Introduction
11.8.4 Cardinal Health Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.8.5 Cardinal Health Recent Development
11.9 Quest Diagnostics
11.9.1 Quest Diagnostics Company Details
11.9.2 Quest Diagnostics Business Overview
11.9.3 Quest Diagnostics Point of Care Infectious Disease Testing Introduction
11.9.4 Quest Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.9.5 Quest Diagnostics Recent Development
11.10 Bio-Rad Labs
11.10.1 Bio-Rad Labs Company Details
11.10.2 Bio-Rad Labs Business Overview
11.10.3 Bio-Rad Labs Point of Care Infectious Disease Testing Introduction
11.10.4 Bio-Rad Labs Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.10.5 Bio-Rad Labs Recent Development
11.11 bioMérieux
11.11.1 bioMérieux Company Details
11.11.2 bioMérieux Business Overview
11.11.3 bioMérieux Point of Care Infectious Disease Testing Introduction
11.11.4 bioMérieux Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.11.5 bioMérieux Recent Development
11.12 Sight Diagnostics
11.12.1 Sight Diagnostics Company Details
11.12.2 Sight Diagnostics Business Overview
11.12.3 Sight Diagnostics Point of Care Infectious Disease Testing Introduction
11.12.4 Sight Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.12.5 Sight Diagnostics Recent Development
11.13 Gene POC
11.13.1 Gene POC Company Details
11.13.2 Gene POC Business Overview
11.13.3 Gene POC Point of Care Infectious Disease Testing Introduction
11.13.4 Gene POC Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.13.5 Gene POC Recent Development
11.14 Trivitron Healthcare
11.14.1 Trivitron Healthcare Company Details
11.14.2 Trivitron Healthcare Business Overview
11.14.3 Trivitron Healthcare Point of Care Infectious Disease Testing Introduction
11.14.4 Trivitron Healthcare Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.14.5 Trivitron Healthcare Recent Development
11.15 OJ-Bio
11.15.1 OJ-Bio Company Details
11.15.2 OJ-Bio Business Overview
11.15.3 OJ-Bio Point of Care Infectious Disease Testing Introduction
11.15.4 OJ-Bio Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.15.5 OJ-Bio Recent Development
11.16 Ortho-Clinical Diagnostics
11.16.1 Ortho-Clinical Diagnostics Company Details
11.16.2 Ortho-Clinical Diagnostics Business Overview
11.16.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Introduction
11.16.4 Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2020-2025)
11.16.5 Ortho-Clinical Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Point of Care Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of HIV POC
 Table 3. Key Players of HBV POC
 Table 4. Key Players of Pneumonia or Streptococcus Associated Infections
 Table 5. Key Players of Respiratory Syncytial Virus (RSV) POC
 Table 6. Key Players of HPV POC
 Table 7. Key Players of Influenza POC
 Table 8. Key Players of Others
 Table 9. Global Point of Care Infectious Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Point of Care Infectious Disease Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Point of Care Infectious Disease Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Point of Care Infectious Disease Testing Market Share by Region (2020-2025)
 Table 13. Global Point of Care Infectious Disease Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Point of Care Infectious Disease Testing Market Share by Region (2026-2031)
 Table 15. Point of Care Infectious Disease Testing Market Trends
 Table 16. Point of Care Infectious Disease Testing Market Drivers
 Table 17. Point of Care Infectious Disease Testing Market Challenges
 Table 18. Point of Care Infectious Disease Testing Market Restraints
 Table 19. Global Point of Care Infectious Disease Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Point of Care Infectious Disease Testing Market Share by Players (2020-2025)
 Table 21. Global Top Point of Care Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Infectious Disease Testing as of 2024)
 Table 22. Ranking of Global Top Point of Care Infectious Disease Testing Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Point of Care Infectious Disease Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Point of Care Infectious Disease Testing, Headquarters and Area Served
 Table 25. Global Key Players of Point of Care Infectious Disease Testing, Product and Application
 Table 26. Global Key Players of Point of Care Infectious Disease Testing, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Point of Care Infectious Disease Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Point of Care Infectious Disease Testing Revenue Market Share by Type (2020-2025)
 Table 30. Global Point of Care Infectious Disease Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Point of Care Infectious Disease Testing Revenue Market Share by Type (2026-2031)
 Table 32. Global Point of Care Infectious Disease Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Point of Care Infectious Disease Testing Revenue Market Share by Application (2020-2025)
 Table 34. Global Point of Care Infectious Disease Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Point of Care Infectious Disease Testing Revenue Market Share by Application (2026-2031)
 Table 36. North America Point of Care Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Point of Care Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Point of Care Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Point of Care Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Point of Care Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Point of Care Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Point of Care Infectious Disease Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Point of Care Infectious Disease Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Point of Care Infectious Disease Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Point of Care Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Point of Care Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Point of Care Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Point of Care Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Point of Care Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Point of Care Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Alere Company Details
 Table 52. Alere Business Overview
 Table 53. Alere Point of Care Infectious Disease Testing Product
 Table 54. Alere Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 55. Alere Recent Development
 Table 56. Thermo Fisher Scientific Company Details
 Table 57. Thermo Fisher Scientific Business Overview
 Table 58. Thermo Fisher Scientific Point of Care Infectious Disease Testing Product
 Table 59. Thermo Fisher Scientific Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 60. Thermo Fisher Scientific Recent Development
 Table 61. F. Hoffmann-La Roche Company Details
 Table 62. F. Hoffmann-La Roche Business Overview
 Table 63. F. Hoffmann-La Roche Point of Care Infectious Disease Testing Product
 Table 64. F. Hoffmann-La Roche Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 65. F. Hoffmann-La Roche Recent Development
 Table 66. Siemens Healthineers Company Details
 Table 67. Siemens Healthineers Business Overview
 Table 68. Siemens Healthineers Point of Care Infectious Disease Testing Product
 Table 69. Siemens Healthineers Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 70. Siemens Healthineers Recent Development
 Table 71. BD Company Details
 Table 72. BD Business Overview
 Table 73. BD Point of Care Infectious Disease Testing Product
 Table 74. BD Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 75. BD Recent Development
 Table 76. Chembio Diagnostics Company Details
 Table 77. Chembio Diagnostics Business Overview
 Table 78. Chembio Diagnostics Point of Care Infectious Disease Testing Product
 Table 79. Chembio Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 80. Chembio Diagnostics Recent Development
 Table 81. Trinity Biotech Company Details
 Table 82. Trinity Biotech Business Overview
 Table 83. Trinity Biotech Point of Care Infectious Disease Testing Product
 Table 84. Trinity Biotech Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 85. Trinity Biotech Recent Development
 Table 86. Cardinal Health Company Details
 Table 87. Cardinal Health Business Overview
 Table 88. Cardinal Health Point of Care Infectious Disease Testing Product
 Table 89. Cardinal Health Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 90. Cardinal Health Recent Development
 Table 91. Quest Diagnostics Company Details
 Table 92. Quest Diagnostics Business Overview
 Table 93. Quest Diagnostics Point of Care Infectious Disease Testing Product
 Table 94. Quest Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 95. Quest Diagnostics Recent Development
 Table 96. Bio-Rad Labs Company Details
 Table 97. Bio-Rad Labs Business Overview
 Table 98. Bio-Rad Labs Point of Care Infectious Disease Testing Product
 Table 99. Bio-Rad Labs Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 100. Bio-Rad Labs Recent Development
 Table 101. bioMérieux Company Details
 Table 102. bioMérieux Business Overview
 Table 103. bioMérieux Point of Care Infectious Disease Testing Product
 Table 104. bioMérieux Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 105. bioMérieux Recent Development
 Table 106. Sight Diagnostics Company Details
 Table 107. Sight Diagnostics Business Overview
 Table 108. Sight Diagnostics Point of Care Infectious Disease Testing Product
 Table 109. Sight Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 110. Sight Diagnostics Recent Development
 Table 111. Gene POC Company Details
 Table 112. Gene POC Business Overview
 Table 113. Gene POC Point of Care Infectious Disease Testing Product
 Table 114. Gene POC Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 115. Gene POC Recent Development
 Table 116. Trivitron Healthcare Company Details
 Table 117. Trivitron Healthcare Business Overview
 Table 118. Trivitron Healthcare Point of Care Infectious Disease Testing Product
 Table 119. Trivitron Healthcare Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 120. Trivitron Healthcare Recent Development
 Table 121. OJ-Bio Company Details
 Table 122. OJ-Bio Business Overview
 Table 123. OJ-Bio Point of Care Infectious Disease Testing Product
 Table 124. OJ-Bio Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 125. OJ-Bio Recent Development
 Table 126. Ortho-Clinical Diagnostics Company Details
 Table 127. Ortho-Clinical Diagnostics Business Overview
 Table 128. Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Product
 Table 129. Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2020-2025) & (US$ Million)
 Table 130. Ortho-Clinical Diagnostics Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. Point of Care Infectious Disease Testing Picture
 Figure 2. Global Point of Care Infectious Disease Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Point of Care Infectious Disease Testing Market Share by Type: 2024 VS 2031
 Figure 4. HIV POC Features
 Figure 5. HBV POC Features
 Figure 6. Pneumonia or Streptococcus Associated Infections Features
 Figure 7. Respiratory Syncytial Virus (RSV) POC Features
 Figure 8. HPV POC Features
 Figure 9. Influenza POC Features
 Figure 10. Others Features
 Figure 11. Global Point of Care Infectious Disease Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 12. Global Point of Care Infectious Disease Testing Market Share by Application: 2024 VS 2031
 Figure 13. Hospitals Case Studies
 Figure 14. Clinics Case Studies
 Figure 15. Home Case Studies
 Figure 16. Others Case Studies
 Figure 17. Point of Care Infectious Disease Testing Report Years Considered
 Figure 18. Global Point of Care Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Point of Care Infectious Disease Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Point of Care Infectious Disease Testing Market Share by Region: 2024 VS 2031
 Figure 21. Global Point of Care Infectious Disease Testing Market Share by Players in 2024
 Figure 22. Global Top Point of Care Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Infectious Disease Testing as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Point of Care Infectious Disease Testing Revenue in 2024
 Figure 24. North America Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Point of Care Infectious Disease Testing Market Share by Country (2020-2031)
 Figure 26. United States Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Point of Care Infectious Disease Testing Market Share by Country (2020-2031)
 Figure 30. Germany Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Point of Care Infectious Disease Testing Market Share by Region (2020-2031)
 Figure 38. China Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Point of Care Infectious Disease Testing Market Share by Country (2020-2031)
 Figure 46. Mexico Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Point of Care Infectious Disease Testing Market Share by Country (2020-2031)
 Figure 50. Turkey Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Point of Care Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Alere Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 55. F. Hoffmann-La Roche Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 56. Siemens Healthineers Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 57. BD Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 58. Chembio Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 59. Trinity Biotech Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 60. Cardinal Health Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 61. Quest Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 62. Bio-Rad Labs Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 63. bioMérieux Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 64. Sight Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 65. Gene POC Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 66. Trivitron Healthcare Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 67. OJ-Bio Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 68. Ortho-Clinical Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart